Jackson Creek Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Jackson Creek Investment Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-66,016	Closed	-$1.13M	–	358
2021 Q3	$1.13M	Buy	66,016 +748	+1%	+$13.1K	0.42%	84
2021 Q2	$1.4M	Sell	65,268 -5,985	-8%	-$107K	0.52%	20
2021 Q1	$1.07M	Sell	71,253 -2,115	-3%	-$34.2K	0.37%	136
2020 Q4	$964K	Buy	+73,368	New	+$883K	0.38%	130

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jackson Creek Investment Advisors's VNDA Position: Q4 2021 in Review

Jackson Creek Investment Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 66,016 shares — an estimated $1.13M sold.

Jackson Creek Investment Advisors first reported a position in VNDA in Q4 2020 and held it in 4 quarters. The position peaked at $1.4M in Q2 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

Jackson Creek Investment Advisors reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Jackson Creek Investment Advisors sold 66,016 Vanda Pharmaceuticals shares in Q4 2021, an estimated $1.13M.
Jackson Creek Investment Advisors first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Jackson Creek Investment Advisors's Vanda Pharmaceuticals position peaked at $1.4M in Q2 2021.
198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Jackson Creek Investment Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.